Radiation for lung or chest cancers in specific locations
Part of Cancer, Lungs & breathing clinical trials.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctors have confirmed you have a malignant (cancer) tumor on pathology testing
- Your tumor is in one of the eligible chest sites (one of five types) and measures 5 cm or less
- You do not have widespread body metastases, or if you do, they must be controlled by prior treatment
- Your overall health is good enough for treatment (KPS above 70) and your medical conditions are stable enough for radiotherapy
- You can lie flat and cooperate during treatment, and your breathing/lung function is adequate
- Your expected life expectancy is at least 3 months, and you can follow the study plan (no severe untreated mental health issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a higher dose of radiation to the chest (after a previous round of radiation at least 6 months ago) is safe and effective for people with lung cancer, esophageal cancer, or cancer that has spread to the chest. It aims to find the best dose that does not cause severe side effects.
This trial tests a focused form of radiation (SBRT) to treat tumors in the very center of the chest that have already been treated with radiation before. It aims to check safety and whether the tumor can be controlled without causing unacceptable side effects.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.